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Abstract 
Background: In this cross‑sectional study we investigated the oral mucosal changes in a middle‑aged Finnish popu‑
lation. We analyzed the prevalence of potentially malignant disorders and the influence of smoking, snuff and alcohol 
use on the mucosal changes.
Methods: Of the 12,068 members of the NFBC 1966, a total of 1961 participants (16.2%) constituted the study 
population. Mucosal changes were diagnosed and photographed by seven general dentists, and two specialists re‑
analyzed all the diagnoses based on the documentation Cross‑tabulation with Chi‑square tests and logistic regression 
analysis were used to analyze the data.
Results: Of the participants, 10.5% had some mucosal changes, of which 81.8% were diagnosed as oral mucosal 
lesions (OML) and 18.2% as normal variations. Of the normal variations, the most common were Fordyce granules 
(1.2%), fissured tongue (1.1%) and geographic tongue (0.9%). The most common OMLs were white lesions (6.5%), of 
which oral lichen planus (OLP) and lichenoid reactions (OLR), grouped as oral lichenoid diseases, were present in 3.5%, 
males more often (3.8% vs. 3.1%). OLP was found in 1.5% of all participants, females more often (1.8% vs. 1.2%), while 
OLR was more common in males (2.7% vs. 1.3%). Leukoplakia was identified in 0.5% of the population; twice more 
often in males (0.6% vs. 0.3%). Erythroplakia was not found. Current smokers had higher risk for oral mucosal changes 
than former or non‑smokers (OR 3.0, 95% CI 2.11–4.28), and snuff, used occasionally or regularly, also raised the risk 
(OR 2.6, 95% CI 1.48–4.70).
Conclusions: In the middle‑aged northern Finland population, 4% of OMLs were potentially malignant disorders, 
including OLR (2%), OLP (1.5%) and leukoplakia (0.5%). In particular, smoking and snuff use increased the risk for hav‑
ing any oral mucosa changes.
Keywords: NFBC, Cross‑sectional study, Middle‑aged population, Oral mucosa, Normal variations and lesions, Oral 
lichen planus, Oral lichenoid reaction, Prevalence, Leukoplakia
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Introduction
The prevalence of oral mucosal changes ranges between 
10.8 and 61.6% in various populations [1–6]. Differ-
ences in the reported prevalence can be explained by 
study protocol, participant individual selection, genet-
ics, age, and sex, as well as local and general risk factors 
in the study population [1, 2]. Oral mucosal changes can 
be divided by clinical features into the following major 
groups: normal variations and oral mucosal lesions 
(OML), including vesiculobullous lesions, ulcerative 
conditions, white lesions, red-blue lesions, pigmented 
lesions, verruca-papillary lesions, tongue and buccal 
Open Access
*Correspondence:  tuula.salo@helsinki.fi
1 Cancer and Translational Medicine Research Unit, Faculty of Medicine, 
University of Oulu, P.O. Box 5281, 90014 Oulu, Finland
Full list of author information is available at the end of the article
Page 2 of 9Oivio et al. BMC Oral Health          (2020) 20:357 
mucosa swellings, gingival swellings, palatal swellings 
and floor of mouth swellings [7].
White lesions are relatively common in the oral cav-
ity, of which some are related to mucocutaneous dis-
eases [8]. Manifestation of oral lichen planus (OLP) is 
variable, being typically symmetrical white and reticu-
lar striae [7–10]. Based on a recent systematic review, 
the malignant transformation of OLP occurs in 1.4% of 
cases [11]. Around 60–80% of OLP patients are reported 
to be women [9, 10], and the typical age of its onset is 
30–60 years [7, 9, 10]. Oral lichenoid reaction (OLR) dif-
fers clinically and/or histopathologically from OLP, usu-
ally occurring unilaterally [12, 13]. OLR may be caused by 
several factors, such as drugs, trauma and dental restora-
tive materials [13], and 3.8% of OLRs are shown to trans-
form into cancer [11]. OLP and OLR can clinically be 
grouped together and termed as oral lichenoid diseases 
(OLD) [12, 14].
Tobacco, snuff and chronic irritation often cause white 
hyperkeratosis [7], but leukoplakia is defined as a white 
patch or plaque that cannot be scratched off or clini-
cally considered to be caused by any traumatic irrita-
tion from any other disease [7, 15, 16]. Tobacco use may 
induce leukoplakia [16, 17]. Malignant transformation of 
leukoplakia has recently been reported to be 9.5% [11]. 
Oral leukoplakia, OLP, OLR, oral submucous fibrosis 
and erythroplakia all belong to a group of oral potentially 
malignant disorders [11, 16].
The incidence of OMLs increases with age, partially 
due to physiological changes in the oral cavity but also 
due to the sustained impact of risk habits. Decreased 
saliva flow and long-lasting effects of local and systemic 
factors, such as alcohol intake, smoking, snuff and drug 
use predispose individuals to various lesions which are 
not present in children, unlike some normal mucosal var-
iations, such as geographic tongue, which already exist 
among youth [3, 7, 18].
The main purpose of this study was to screen all 
mucosal changes in the Northern Finland middle-aged 
(45–47-year-old) participants and to evaluate their asso-
ciation with smoking, use of snuff and alcohol intake. To 
the best of our knowledge, this is the only study carried 
out on the prevalence of oral mucosal changes in a Finn-
ish population that was selected only for the year of birth 
(1966), but not for any other factors.
Materials and methods
Study population
The study population is part of the longitudinal North-
ern Finland Birth Cohort 1966 (NFBC 1966) [20]. 
The entire cohort included 12,055 mothers whose 
expected delivery was in the year 1966. Altogether 
12,231 children were born, 12,058 of whom were born 
alive. NFBC 1966 data have been collected with health 
questionnaires and clinical examinations at the ages of 
around 1, 14, 31 and 46 years. Since the 46-years clini-
cal examination was performed between April 2012 and 
June 2013, and depending on the month the examinee 
was born, their age ranged from 45 to 47 years. Health 
questionnaires and written data from the oral mucosal 
clinical examination and pictures of 1,961 participants 
were also collected; see details below [20].
Health questionnaires
In connection with the 46-year examination, all cohort 
members were sent the postal questionnaires, which 
they filled in either on the internet or on paper. The 
questionnaire covered general health, sex, alcohol 
intake, smoking and use of snuff. Following the ques-
tionnaire, an invitation to a clinical examination was 
sent to all cohort participants.
Smoking status was assessed in the postal question-
naire as follows: “Have you ever smoked in your life?” 
(no, yes, I started at the age of XX), “Have you smoked 
regularly?” (no, yes, I have smoked regularly for a total 
of XX years), “If you have quit smoking, what age were 
you when you stopped?”, “Do you smoke currently?” 
(7 days a week, 5–6 days a week, 2–4 days a week, 1 day 
a week, occasionally, not at all). Usage of snuff was 
assessed as follows: “Do you use snuff currently?” (no, 
occasionally, regularly).
Alcohol consumption was queried in the question-
naire as follows: “How often do you usually drink beer, 
cider, long drinks or wine, fortified wines, homemade 
wines or hard liquors?” (never, less than once a year, 
a couple times a year, 3–4 times a year, once every 
2 months, once a month, a couple times a month, once 
a week, a few times a week, daily), “How much beer, 
cider or long drinks do you usually drink on one occa-
sion? (1 bottle = 1/3 L)” (less than 1 bottle, 1 bottle, 2 
bottles, 3 bottles, 4–5 bottles, 6–9 bottles, 10–14 bot-
tles, 15 bottles or more, I don’t drink any of these bev-
erages), “How much wine, fortified wine or homemade 
wine do you usually drink on one occasion? (half glass, 
one glass (= 16 cl), a couple of glasses, about half of the 
bottle (large bottle = ¾ l), a bit more than a large bottle, 
about one large bottle, one or two large bottles, more 
than two large bottles, I don’t drink wine), “How much 
hard liquor do you usually drink on one occasion? (less 
than 1 tavern portion (less than 4 cl), 1 tavern portion 
(about 4 cl), 2 tavern portions, 3–4 tavern portions, 5–6 
tavern portions, 7–10 tavern portions, about a half-litre 
bottle, more than a half-litre bottle, I don’t drink hard 
liquor).
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Oral examination
In the 46-year follow-up survey, altogether 3150 per-
sons currently living in the city of Oulu or within a 
radius of 100  km were asked to participate in the oral 
examination, including oral mucosa and dental exami-
nation. Of the original subgroup, a total of 1961 per-
sons (62.3%) attended the clinical oral examination and 
gave their consent to use the data; these persons com-
prised the present study population. The clinical oral 
examination was performed between April 2012 and 
June 2013.
The oral examination was conducted by seven gen-
eral dentists during the period 2012–2013. All examin-
ers used a standard clinical dental examination protocol. 
They were trained and calibrated by Oulu University 
dental clinic teachers, not including oral medicine spe-
cialists, before the examination and at the middle of the 
study period. All examinations were made in the Oulu 
University dental clinic with modern supplies and opti-
mal light. Clinical examination of the oral cavity included 
a careful and systematic visual inspection of the whole 
oral cavity. Dentists also made a palpation for all areas of 
the oral mucosa. Biopsy was not taken. All oral mucosal 
changes were written documented and photographed 
during the clinical examinations. All examiners used the 
same type of camera (CANON 600D 60 mm Lens Macro 
1:2,8, Flash Sigma EM-140 DG).
Diagnoses for the mucosal changes
Afterwards, oral pathologist (TS) and oral mucosal dis-
ease specialists (AK, TS) simultaneously re-analysed all 
the pictures and, based on them and on the documen-
tation by the general dentists, they provided consensus 
diagnoses for all the findings. Specialists disagreed in 
24.3% of the lesions and agreed in 54.8% of the proposed 
diagnosis by the general dentists. Of the documented 
lesions, 20.9% had no proposed diagnosis by the general 
dentists and were diagnosed afterwards based documen-
tation and pictures by two specialists. The total number 
of examinees who had oral mucosal lesions was 206. 
There were no false-positive cases.
Statistical analysis
The study population was described using frequen-
cies and percentages with the categorical variables gen-
der, smoking, snuff use and alcohol intake as shown in 
Table  1. Smoking was categorised as current smokers, 
former smokers and non-smokers, and snuff usage as 
snuff-users and non-users. The consumption of alcohol 
(g/day) was calculated based on the questions concern-
ing alcohol usage. Alcohol intake was categorised such 
that the heavy user limit for females was 20 g/day and for 
males 30 g/day.
The number of mucosal lesions per person was calcu-
lated, and lesions and diseases were categorised into 11 
main groups based on the Regezi et  al. textbook [7] as 
following: no changes, normal variations, vesiculobul-
lous lesions, ulcerative conditions, white lesions, red-blue 
lesions, pigmented lesions, verruca-papillary lesions, 
connective tissue lesions (CTL), divided by region into 
tongue and buccal mucosal swellings, gingival swellings 
and floor of mouth swellings.
Cross-tabulation with Chi-square or Fisher’s exact test 
was used to compare the numbers of mucosal lesions, 
submucosal swellings, oral mucosal variations and 
mucosal diseases between genders. Additionally, the 
association between lesions and smoking within gender 
as well as association between lesions and gender within 
smoking have been analysed using cross-tabulation with 
Chi-square or Fisher’s exact test. Logistic regression anal-
ysis was used to present crude odds ratios (OR) and their 
95% confidence intervals (CI) when comparing current 
and former smokers with non-smokers, snuff users with 
non-users and heavy alcohol users with moderate users 
or non-users. The adjusted logistic regression model was 
executed including smoking, snuff use and alcohol in the 
same model.
Differences between groups were considered statisti-
cally significant at p-values < 0.05. All analyses were per-




The total number of clinically examined participants 
was 1961; women comprised 53.5% (n = 1050) of the 
Table 1 Characteristics of the study population
Total Male Female
n (%) n (%) n (%)
Tobacco
 Current smoker 343 (18.3) 167 (19.2) 176 (17.5)
 Former smoker 534 (28.5) 291 (33.4) 243 (24.2)
 Non‑smoker 999 (53.3) 413 (47.4) 586 (58.3)
Snuff
 Regular user 31 (1.6) 30 (3.4) 1 (0.1)
 Occasional user 39 (2.1) 38 (4.3) 1 (0.1)
 Non‑user 1820 (96.3) 810 (92.3) 1010 (99.8)
Alcohol
 Heavy user 232 (12.2) 150 (17.0) 82 (8.0)
 Normal user 1673 (87.8) 732 (83.0) 941 (92.0)
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population. The mean age was 46  years. The number 
of participants who answered the questions concern-
ing smoking was 1876 (95.7%). We divided smokers into 
three categories: current smokers (18.3%), former smok-
ers (28.5%) and non-smokers (53.3%). Concerning snuff 
use, 1890 participants (96.4%) answered the questions: 
1012 females (96.3%) and 878 males (96.3%). The propor-
tion of snuff users was 3.7%, of which 0.2% were females 
and 7.7% males of the entire population. Concerning 
alcohol intake, 1905 participants (97.1%) answered the 
questions: 882 males (46.3%) and 1023 females (53.7%). 
In this study, 8.0% of females and 17.0% of males were 
heavy users (Table 1).
Prevalence of oral mucosal normal variations and lesions
Of the participants (n = 1961), 10.5% (n = 206) had some 
mucosal changes, slightly more in men (n = 108). One 
change was registered in 7.4% (n = 145), two in 2.8% 
(n = 54) and three in 0.4% (n = 7) of the participants. 
Males more often than females had two changes (3.7%, 
n = 34 vs. 1.9%, n = 20; p = 0.014).
Altogether, 55 different kinds of changes were 
recorded; 81.8% were diagnosed as OMLs and 18.2% 
belonged to the normal variations category. When we 
categorised lesions into the main groups, the most com-
mon group was white lesions (6.5%, n = 128), followed 
by normal variations (3.3%, n = 64) and red-blue lesions 
(1.3%, n = 25). White lesions were more often diagnosed 
in males (8.1% vs. 5.1%; p = 0.008), whereas pigmented 
lesions were more common in females (1.0% vs. 0.3%; 
p = 0.090). Normal variations were seen more often in 
males (4.1%, n = 37; p = 0.064) (Table 2).
The most common normal variations were the fol-
lowing: Fordyce granules 1.2% (n = 24), fissured tongue 
1.1% (n = 22), geographic tongue 0.9% (n = 18) and hairy 
tongue 0.2% (n = 3) (Table 3) [3, 6].
Of the oral mucosal lesions, the most common findings 
were OLR 2.0% (n = 39), OLP 1.5% (n = 29), hyperkera-
tosis 0.7% (n = 14), fibroma 0.7% (n = 13), snuff-related 
lesions 0.5% (n = 10), amalgam pigmentation 0.4% 
(n = 7), median rhomboid glossitis 0.4% (n = 7), hemangi-
oma 0.3% (n = 6), ulcer 0.3% (n = 6) and candidiasis 0.3% 
(n = 5). Leukoplakia was registered in only 0.5% (n = 9) of 
all participants (n = 1961) (Table 4).
The two most common lesions, OLR and OLP, grouped 
together into OLD, were found in 3.5% of the study 
population: 3.1% in females and 3.9% in males. OLP was 
slightly more common among females (1.8% vs. 1.2%; 
p = 0.354), as was hyperpigmentation associated with 
amalgam (0.6% vs. 0.1%; p = 0.131). Males had OLR sig-
nificantly more often (2.7% vs. 1.3%; p = 0.026), as well 
as hyperkeratosis (1.0% vs. 0.5%; p = 0.179). Addition-
ally, Fordyce granules (2.3% vs. 0.3%; p < 0.001) and 
snuff-related lesions (1.0% vs. 0.0%; p = 0.001) were more 
common in males than females (Tables 3, 4).
Lesions related to tobacco product use
In current smokers, OLP (3.5%, p = 0.001), OLR (4.1%, 
p = 0.016), hyperkeratosis (1.7%, p = 0.007) and snuff-
related lesions (1.5%, p = 0.004) were more common than 
in non- or former smokers. Of all the current smokers 
with OLP, 75% (n = 9, p = 0.095) were females. OLR was 
more common in current smokers (4.1%: males 4.8% and 
females 3.4%), followed by former smokers (1.7%: males 
2.4% and females 0.8%) and non-smokers (1.6%: males 
2.4% and females 1.0%). Similarly, hyperkeratosis was 
Table 2 Oral mucosal normal variations and lesions
CTL = connective tissue lesions
Total Male Female p-value
n (%) n (%) n (%)
No changes 1755 (89.5) 803 (88.1) 952 (90.7) 0.069
Normal variations 64 (3.3) 37 (4.1) 27 (2.6) 0.064
Vesiculobullous lesions 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Ulcerative lesions 4 (0.2) 3 (0.3) 1 (0.1) 0.343
White lesions 128 (6.5) 74 (8.1) 54 (5.1) 0.008
Red‑blue lesions 25 (1.3) 12 (1.3) 13 (1.2) 0.876
Pigmented lesions 13 (0.7) 3 (0.3) 10 (1.0) 0.090
Verruca‑papillary lesions 3 (0.2) 2 (0.2) 1 (0.1) 0.600
CTL: tongue and buccal 
mucosal swellings
18 (0.9) 9 (1.0) 9 (0.9) 0.762
CTL: gingival swellings 5 (0.3) 3 (0.3) 2 (0.2) 0.668
CTL: floor of mouth 
swellings
1 (0.1) 0 (0.0) 1 (0.1) 1.000
Table 3 Prevalence of  normal oral mucosal variations 
and their distribution by sex
Total Male Female p-value
n = 1961 n = 911 n = 1050
n (%) n (%) n (%)
Fordyce granules 24 (1.2) 21 (2.3) 3 (0.3)  < 0.001
Fissured tongue 22 (1.1) 8 (0.9) 14 (1.3) 0.340
Geographic tongue 18 (0.9) 6 (0.7) 12 (1.1) 0.262
Hairy tongue 3 (0.2) 2 (0.2) 1 (0.1) 0.600
Linea alba 2 (0.1) 1 (0.1) 1 (0.1) 1.000
Erythema migrans (lip) 1 (0.1) 0 (0.0) 1 (0.1) 1.000
Exostosis 1 (0.1) 0 (0.0) 1 (0.1) 1.000
Melanotic macule 1 (0.1) 0 (0.0) 1 (0.1) 1.000
Mandible exostosis 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Dry lips 1 (0.1) 1 (0.1) 0 (0.0) 0.465
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more common in current smokers (1.7%, n = 6), com-
pared to former (0.7%, n = 4) and non-smokers (0.2%, 
n = 2) (p = 0.007). Among males, hyperkeratosis was 
detected in 2.4% (n = 4) of current smokers, 0.3% (n = 1) 
of former and 0.5% (n = 2) of non-smokers (p = 0.046). 
Among females, hyperkeratosis was detected in 1.1% 
(n = 2) of current smokers, 1.2% (n = 3) of former and 
in no non-smokers (p = 0.029). Hyperpigmentation 
(0.6%, n = 2; p = 0.033) was only found in current smok-
ers. Snuff-related lesions were present in 1.5% (n = 5) 
of current smokers, 0.7% (n = 4) of former smokers and 
0.1% (n = 1) of non-smokers (p = 0.004). All snuff-related 
lesions were found in males (2.4%, n = 4, p = 0.013). Leu-
koplakia was found in 9 (0.5%) of all participants, and 5 
(1.5%) of them were current smokers, 2 (0.4%) were for-
mer and 2 (0.2%) were non-smokers (p = 0.024) (Table 5).
Of normal variations, geographic tongue was seen in 
1.5% (n = 15) of non-smokers (p = 0.031). In females, 
1.1% (n = 2) of current smokers, no former smokers and 
1.7% (n = 10) of non-smokers had geographic tongue 
(p = 0.089). In males, 1.2% (n = 5) of non-smokers had 
geographic tongue. Fordyce granules were more com-
mon in non-smokers (1.5%, n = 15), particularly in males 
(3.1%, n = 13, p < 0.001), compared to current smokers 
(0.9%, n = 3) or former smokers (0.7%, n = 4) (p = 0.364) 
(Table 5).
Odds ratios and confidence intervals
When we compared non-smokers with current smok-
ers and former smokers, the OR for current smokers was 
3.0 (95% CI 2.11–4.28) for any mucosal changes. Use of 
snuff, occasionally or regularly, raised the risk of having 
mucosal changes (OR 2.6, 95% CI 1.48–4.70). Alcohol 
intake affected the risk for mucosal changes (OR 1.3, 95% 
CI 0.82–1.91). When we included smoking, snuff use and 
alcohol intake in the same adjusted model, the smoking 
and snuff remained significant (Table 6).
Discussion
In this cross-sectional study, we investigated the preva-
lence of oral mucosal changes in the Northern Fin-
land Birth cohort (1966) of 1961 participants at the 
age of 46  years. The overall prevalence of any mucosal 
changes was 10.5%, of which 4% were grouped as poten-
tially malignant disorders: OLD was found in 3.5% and 
Table 4 Prevalence of  oral mucosal lesions and  their 
distribution by sex
Total Male Female p-value
n = 1961 n = 911 n = 1050
n (%) n (%) n (%)
OLR 39 (2.0) 25 (2.7) 14 (1.3) 0.026
OLP 29 (1.5) 11 (1.2) 18 (1.8) 0.354
Hyperkeratosis 14 (0.7) 9 (1.0) 5 (0.5) 0.179
Fibroma 13 (0.7) 6 (0.7) 7 (0.7) 0.983
Snuff‑related lesion 10 (0.5) 10 (1.0) 0 (0.0) < .001
Amalgam pigmentation 7 (0.4) 1 (0.1) 6 (0.6) 0.131
Median rhomboid glossitis 7 (0.4) 4 (0.4) 3 (0.3) 0.711
Candidiasis + thrush 6 (0.3) 5 (0.5) 1 (0.1) 0.103
Hemangioma 6 (0.3) 3 (0.3) 3 (0.3) 1.000
Ulcer 6 (0.3) 3 (0.3) 3 (0.3) 1.000
Hematoma 5 (0.3) 2 (0.2) 3 (0.3) 1.000
Rhagards 4 (0.2) 2 (0.2) 2 (0.2) 1.000
Hyperpigmentation 3 (0.2) 1 (0.1) 2 (0.2) 1.000
Leukoplakia 9 (0.5) 6 (0.7) 3 (0.3) 0.318
Papilloma 3 (0.2) 2 (0.2) 1 (0.1) 0.600
Petechia 3 (0.2) 2 (0.2) 1 (0.1) 0.600
Foliate papilla hyperplasia 2 (0.1) 0 (0.0) 2 (0.2) 0.502
Tongue papilla atrophy 2 (0.1) 0 (0.0) 2 (0.2) 0.502
Oral mucocele/ranula 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Linea alba 2 (0.1) 1 (0.1) 1 (0.1) 1.000
Erythema 2 (0.1) 1 (0.1) 1 (0.1) 1.000
Fistula 2 (0.1) 1 (0.1) 1 (0.1) 1.000
Tobacco hyperpigmentation 2 (0.1) 1 (0.1) 1 (0.1) 1.000
Aphthous ulcer 2 (0.1) 1 (0.1) 1 (0.1) 1.000
Gingiva hyperplasia 2 (0.1) 2 (0.2) 0 (0.0) 0.216
Prosthesis stomatitis 1 (0.1) 0 (0.0) 1 (0.1) 1.000
Mucosal burn 1 (0.1) 0 (0.0) 1 (0.1) 1.000
Glandula sublingualis swell‑
ing
1 (0.1) 0 (0.0) 1 (0.1) 1.000
Salivary calculus 1 (0.1) 0 (0.0) 1 (0.1) 1.000
Papular hyperplasia 1 (0.1) 0 (0.0) 1 (0.1) 1.000
Tongue papule 1 (0.1) 0 (0.0) 1 (0.1) 1.000
White drug reaction (anti‑
biotics)
1 (0.1) 0 (0.0) 1 (0.1) 1.000
Cheek mucosa hyperplasia 1 (0.1) 0 (0.0) 1 (0.1) 1.000
Bite trauma 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Cobblestone hyperplasia 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Desquamative gingivitis 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Hairy leukoplakia 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Herpes simplex infection 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Nicotine stomatitis 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Non‑homogenous leuko‑
plakia
1 (0.1) 1 (0.1) 0 (0.0) 0.465
Palatal ulcer 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Papilla incisor hyperplasia 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Redness of papilla incisor 1 (0.1) 0 (0.0) 1 (0.1) 1.000
Solar cheilitis 1 (0.1) 1 (0.1) 0 (0.0) 0.465
Table 4 (continued)
Total Male Female p-value
n = 1961 n = 911 n = 1050
n (%) n (%) n (%)
Tongue hypertrophy 1 (0.1) 1 (0.1) 0 (0.0) 0.465
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leukoplakia in 0.5% of the study population. Unlike 
alcohol intake, both current smoking and snuff use sig-
nificantly increased the number of mucosal changes. 
In general, males had mucosal lesions more often than 
females, related to their drinking, smoking and snuff use 
habits.
The final diagnoses collected were based on documen-
tation by a general dentist examiner that was later simul-
taneously re-evaluated by two oral mucosal specialists. 
The agreement between the general dentists and spe-
cialist diagnoses was low (54.8%) compared to a Swed-
ish multicentre dental patient study, where 85% of the 
803 cases were given the same diagnosis by the general 
practitioner and two oral mucosal specialists [2]. In our 
cohort, 20.9% of the mucosal changes documented were 
not given any primary diagnosis by the general dentists 
and were only classified by the specialists. This may be 
because the general dentist examiners were unfortu-
nately not well trained in the diagnosis of oral mucosa 
but were better trained in classifying teeth and gingival 
diseases, which were examined during the same visit. The 
lack of biopsy may also hinder with our diagnoses, which 
is a point that should be taken into account in further 
investigations.
The prevalence of oral mucosal changes varies depend-
ing on the published study populations [1–6, 10, 17–28]. 
For example, in a recent evaluation of Slovenian citizens 
(2395 patients, aged 22–92  years) who attended a gen-
eral dental practice, the prevalence of OMLs was 27% 
[3]. A similar result was found in an Italian study (4098 
subjects, age range 19–96 years) where the prevalence of 
OMLs was 25.09% [25]. However, in a southern Indian 
study (1190 patients, age range 2–80 years) conducted in 
a specialist clinic, the prevalence of one or more OMLs 
was clearly higher, 41.2% [21]. In a large Chinese general 
population (n = 11,054) of 1- to 96-year-old inhabitants 
[1], the prevalence of OMLs (10.8%) was almost the same 
as in our cohort (10.5%), but less than in a Swedish study 
(6448 adults, mean age = 56.0), where OMLs were found 
in 14.7% of the participants [2]. The higher prevalence in 
the Slovenian, Italian, Indian and Swedish cohorts may 
also reflect the heavy use of tobacco in Slovenia and Italy, 
betel in India, and snuff in Sweden, which increase the 
incidence of OMLs.
Here, the ten most common mucosal findings were 
OLR, OLP, Fordyce granules, hyperkeratosis, fissured 
tongue, geographic tongue, fibroma, snuff-related 
lesions, amalgam pigmentation and median rhomboid 
glossitis. When comparing our results to other publica-
tions, similar lesions are often recorded, but their preva-
lence seems to vary depending on the study population 
[1–3]. Some studies have focused on analysing mucosal 
lesions that raise a risk of oral cancer, or are associated 
with risk habits, such as smoking or denture wearing [22, 
23, 25, 27]. In our study, we did not compare the presence 
of OMLs to chronic irritation, like dentures, which would 
Table 5 Lesions associated with smoking and sex
a Comparation between smoking






n = 343 n = 534 n = 999
n (%) n (%) n (%)
OLP
 Male 3 (1.8) 3 (1.0) 3 (0.7) 0.500
 Female 9 (5.1) 2 (0.8) 6 (1.0) 0.002
 Total 12 (3.5) 5 (0.9) 9 (0.9) 0.001
 p-valueb 0.095 1.000 0.743
OLR
 Male 8 (4.8) 7 (2.4) 10 (2.4) 0.255
 Female 6 (3.4) 2 (0.8) 6 (1.0) 0.070
 Total 14 (4.1) 9 (1.7) 16 (1.6) 0.016
 p-valueb 0.518 0.192 0.083
Leukoplakia
 Male 3 (1.8) 2 (0.7) 1 (0.2) 0.092
 Female 2 (1.1) – 1 (0.2) 0.125
 Total 5 (1.5) 2 (0.4) 2 (0.2) 0.024
 p-valueb 0.678 0.503 1.000
Hyperkeratosis
 Male 4 (2.4) 1 (0.3) 2 (0.5) 0.046
 Female 2 (1.1) 3 (1.2) 0 (0.0) 0.029
 Total 6 (1.7) 4 (0.7) 2 (0.2) 0.007
 p-valueb 0.374 0.335 0.171
Hyperpigmentation
 Male 1 (0.6) 0 (0.0) 0 (0.0) 0.192
 Female 1 (0.6) 0 (0.0) 0 (0.0) 0.175
 Total 2 (0.6) 0 (0.0) 0 (0.0) 0.033
 p-valueb 1.000 – –
Snuff-related lesion
 Male 5 (3.0) 4 (1.4) 1 (0.2) 0.013
 Female 0 (0.0) 0 (0.0) 0 (0.0) –
 Total 5 (1.5) 4 (0.7) 1 (0.1) 0.004
 p-valueb 0.027 0.130 0.413
Geographic tongue
 Male 0 (0.0) 1 (0.3) 5 (1.2) 0.341
 Female 2 (1.1) 0 (0.0) 10 (1.7) 0.089
 Total 2 (0.6) 1 (0.2) 15 (1.5) 0.031
 p-valueb 0.499 1.000 0.526
Fordyce granules
 Male 2 (1.2) 4 (1.4) 13 (3.1) 0.178
 Female 1 (0.6) 0 (0.0) 2 (0.3) 0.555
 Total 3 (0.9) 4 (0.7) 15 (1.5) 0.364
 p-valueb 0.614 0.130  < 0.001
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have been worth conducting. The population reports 
have often focused on the prevalence of OMLs in adults 
of all ages including sometimes children sometimes not 
[1, 3, 17, 19, 27], therefore, it is not possible to directly 
compare results of our cohort of 45–47-year-olds with 
those.
Of normal variations, we detected mostly Fordyce 
granules, in 1.2% of the participants, whereas in the Chi-
nese all-aged general population, the prevalence was only 
0.5% [1], and in the Swedish adult study Fordyce granules 
were not listed [2]. generally, the prevalence of Fordyce 
granules has been higher than in our cohort: in Slovenia 
1.9% [3], in Turkey 2.8% [19] and in India 6.6% [21] of the 
study population.
The most common OML was a white lesion group 
(6.5%) including OLP, OLR, hyperkeratosis, snuff-related 
lesion, leukoplakia and candidiasis, found more often 
in males (8.1% vs. 5.1%). In a Turkish study [19], white 
lesions were found in only 2.2% of the 5000 consecutive 
17–85-year-old patients, whereas ulcerated lesions were 
recorded most often (6.6%), which we recorded in only 
0.2% of participants.
The prevalence of OLP was 1.5%, similar as in Italy 
(1.46%), but higher than in China (0.8%), Turkey (0.8%), 
India (1.3%), or a more recent study from Slovenia (1.1%) 
[1, 3, 19, 21, 25]. However, in an earlier Slovenian study, 
OLP was found twice as often as the more recent study, 
in 2.3% of the participants [5]. In Cambodia, 1.8% of 1319 
individuals studied had OLP [27]. Overall, our result of 
the OLP prevalence seems to fit well within the various 
reports ranging from 0.8% to 2.3%. Of the OLP patients, 
62% were females, and it affected 1.8% of all females and 
1.2% of all males. In a Swedish study (of over 30-year-
olds), OLP was also more frequent among females (2.2% 
vs. 1.6%) [26], and in Slovenia, OLP was up to twice as 
common in females (3% vs. 1.5%) [5]. Interestingly, in 
a Cambodian population, OLP was only detected in 
females [27], whereas there were no sex-related differ-
ences in the prevalence of OLP in a Turkish study [19]. 
These results indicate that OLP in most, but not all, pop-
ulations seem to be more common among females.
When we compared OLP with OLR, the prevalence of 
OLD was 3.5%, which is higher than in the most recent 
Swedish study [2], as well as in the Italian study (2.4% and 
1.75%, respectively). Our higher prevalence may also be 
due to some misdiagnoses based on clinical images only, 
without biopsies, which were taken in the Italian study to 
confirm the diagnoses [25].
We registered leukoplakia in 9 (0.5%) of the partici-
pants, of which 5 were current, 2 former and 2 non-
smokers. The prevalence of leukoplakia in our study 
was in a similar range as in recent Swedish [2] and Slo-
venian [3] studies where leukoplakia was found in 0.4% 
and 0.5%, respectively. However, in the Swedish study 
from 30  years ago, the prevalence of leukoplakia was 
higher (3.6%), and most of them (2.9%) were associated 
with tobacco [17]. In a recent Indian study, leukoplakia 
was detected in 5.7% of the 300 participants [27]. There 
are two studies from Italy in which the prevalence of oral 
leukoplakia varies significantly; in the randomly selected 
male participants over 40  years of age (n = 118) from 
northern Italy [10], the prevalence of leukoplakia was 
13.8%, whereas of the 4098 male and female participants 
in the Turin area, leukoplakia was registered in 1.15%. In 
both studies, leukoplakia was more common in current 
smokers than in never smokers [10, 28]. Since smoking is 
more popular in India and Italy than in Finland currently, 
that can explain the higher number of leukoplakia lesions 
in those populations.
Smoking in Finland has decreased during the last 
decades, and in 2018, of the 20–64-year-old popula-
tion, 14% were daily smokers [29], but in this northern 
Table 6 Crude ORs and  95% CIs for  any mucosal changes or  diseases in  association with  smoking, snuff and  alcohol 
comparing current smokers and former smokers to non-smokers, snuff users to non-snuff users and alcohol heavy users 
to normal users
Crude OR (95% CI) p-value Adjusted OR (95% CI) p-value
Smoking
 Current smoker 3.0 (2.11–4.28)  < 0.001 2.9 (2.03–4.18)  < 0.001
 Former smoker 1.3 (0.93–1.93) 0.120 1.3 (0.89–1.87) 0.178
 Non‑smoker (reference) 1.0 1.0
Snuff
 Use occasionally or regularly 2.6 (1.48–4.70) 0.001 2.4 (1.31–4.36) 0.005
 Non‑snuff user (reference) 1.0 1.0
Alcohol
 Heavy user 1.3 (0.82–1.91) 0.290 0.9 (0.59–1.43) 0.703
 Normal user (reference) 1.0 1.0
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Finland cohort 18% were still active smokers. The three 
most common lesions in smokers were OLP, hyperker-
atosis and OLR. Current smokers had also more OLP 
than former or non-smokers, and current female smok-
ers had OLP more often than males (5.7% vs. 1.8%). In 
Slovenia, OLP was diagnosed in only 1.5% of smokers 
(n = 392) [3], whereas in our study OLP was more than 
twice as common in current smokers (3.8%). Interest-
ingly, for some reason geographic tongue was signifi-
cantly more common in non-smokers (1.5%) than in 
current smokers (0.6%), similar to that seen in a Swed-
ish study where 6.8% of non-smokers and 1.7% of smok-
ers had a geographic tongue [30].
The use of snuff is lower in Finland compared to Swe-
den, but it has recently increased, especially among 
the youth. Although snuff is not sold in Finland, Swed-
ish snuff is brought to Finland from Sweden. Based on 
the Finnish National Institute for Health and Welfare 
statistics 2018, about 5% of Finnish 20–64-year-old 
males and 0–1% of females used snuff daily [29]. In our 
cohort, the number of snuff users was 3.7% (n = 70), 
44% used it regularly, and 2 were females. The three 
most common lesions in snuff users were snuff-related 
local lesions (14.3%), Fordyce granules (5.7%) and OLR 
(2.9%). None of the snuff users had OLP or leukoplakia. 
In the most recent Swedish report, snuff dipper’s lesion 
was found in 4.8% of the study population, but in that 
study the snuff users other mucosal changes were not 
recorded [2].
Conclusions
In conclusion, this study provides data about the preva-
lence of oral mucosal changes in a middle-aged north-
ern Finland population cohort. Although it is difficult to 
compare prevalence rates from different studies, these 
results are mainly in line with data reported by previous 
studies. The fact that 4% of the OMLs found here can be 
grouped as a potentially malignant disorder emphasises 
the importance of routine inspections and follow-ups of 
OMLs. Moreover, the importance of risk factors (tobacco 
and snuff) in the pathogenesis of mucosal changes is 
evidenced.
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